Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · IEX Real-Time Price · USD
1.750
+0.050 (2.94%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $259.44 million as of April 26, 2024. Its market cap has decreased by -13.32% in one year.
Market Cap
259.44M
Enterprise Value
416.18M
1-Year Change
-13.32%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since June 21, 2018, Xeris Biopharma Holdings's market cap has decreased from $384.90M to $259.44M, a decrease of -32.59%. That is a compound annual growth rate of -6.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 245.80M | 2.93% |
Apr 25, 2024 | 238.80M | -3.40% |
Apr 24, 2024 | 247.20M | -1.12% |
Apr 23, 2024 | 250.00M | - |
Apr 22, 2024 | 250.00M | 2.29% |
Apr 19, 2024 | 244.40M | -1.13% |
Apr 18, 2024 | 247.20M | -1.12% |
Apr 17, 2024 | 250.00M | -1.11% |
Apr 16, 2024 | 252.80M | -2.69% |
Apr 15, 2024 | 259.80M | -3.17% |
Apr 12, 2024 | 268.30M | -5.89% |
Apr 11, 2024 | 285.10M | 2.52% |
Apr 10, 2024 | 278.10M | -1.97% |
Apr 9, 2024 | 283.70M | - |
Apr 8, 2024 | 283.70M | -0.98% |
Apr 5, 2024 | 286.50M | -0.49% |
Apr 4, 2024 | 287.90M | -1.44% |
Apr 3, 2024 | 292.10M | -0.48% |
Apr 2, 2024 | 293.50M | -2.36% |
Apr 1, 2024 | 300.60M | -3.16% |
Mar 28, 2024 | 310.40M | 8.34% |
Mar 27, 2024 | 286.50M | -0.49% |
Mar 26, 2024 | 287.90M | -2.87% |
Mar 25, 2024 | 296.40M | 0.47% |
Mar 22, 2024 | 295.00M | -1.40% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cybin | 260.88M |
Sight Sciences | 260.16M |
Invivyd | 259.31M |
ESSA Pharma | 256.36M |
ChromaDex | 256.11M |
Pyxis Oncology | 255.21M |
Bioventus | 250.99M |
Fennec Pharmaceuticals | 250.95M |